5th Invest in ME
International ME/CFS Conference 2010
A New Era of ME/CFS Research
Welcome to the
in ME International ME/CFS Conference 2010 in Westminster, London,
UK, on 24th May 2010.
The key to
resolving, treating and curing ME/CFS lies in biomedical research.
from a knowledge of the biomedical research which is ongoing it is
necessary for healthcare staff to be aware of the multiple symptoms
exhibited by ME patients and of the possible treatments available.
of healthcare staff about ME/CFS now needs to break with the past
and reflect the newfound knowledge about the pathogenesis of ME/CFS
which high quality biomedical research is providing.
will be oriented toward providing healthcare staff and others with
knowledge of the latest research and the biomarkers which allow
appropriate treatments to be prescribed.
conference focused on Sub Grouping and Treatments and showed
indisputable proof from leading ME/CFS experts regarding the
pathology of this illness.
conference concentrated on the severely-affected patients with
With the recent
discovery of the xenotropic murine leukemia virus-related virus
(XMRV) in patients with ME/CFS by the Whittemore-Peterson Institute,
the US National Cancer Institute and the Cleveland Clinic of Ohio,
we are witnessing a major breakthrough in attitudes toward reseach
and experiences of managing and treating ME/CFS will be presented as
will findings from the latest biomedical research.
The time is
right for a scientific approach to research and treatment associated
in ME are pleased to announce the following speakers at the
Professor Brigitte Huber PhD
Brigitte Huber is Professor of pathology at Tufts University School
of Medicine in Boston. She has studied the presence of a specific
retrovirus(HERV-K18) as a predictor for ME/CFS, as people who
develop ME/CFS may be susceptible to activation of this ancient
retrovirus in the human genome.
Dr Judy Mikovits PhD
Judy Mikovits is Research Director at the Whittemore Peterson Nevada CFS centre for
Neuro-Immune disorders and has co-authored over 40 peer reviewed
publications that address fundamental issues of viral pathogenesis,
hematopoiesis and cytokine biology.
Dr Mikovits is one of the authors of the ground-breaking
study published in Science magazine in October 2009 which detected
XMRV in CFS patients (Detection of an infectious retrovirus, XMRV, in blood cells of patients with
chronic fatigue syndrome).
Dr Jonathan Kerr MD, PhD
Sir Joseph Hotung Senior Lecturer in Inflammation, St George's
University of London.
Dr Kerr has published several papers on CFS and gene expression the
latest one being:
Differentially expressed genes in Chronic Fatigue Syndrome / Myalgic
Encephalomyelitis (CFS/ME) patients reveal seven subtypes with
distinct clinical phenotypes.
Dr Paul Cheney MD, PhD
Paul Cheney is Medical Director of the Cheney Clinic in Asheville,
North Carolina. Dr. Cheney has been a pioneering clinical researcher
in the field of ME/CFS and is an internationally recognized
authority on the illness. He has lectured around the world and is
author/co-author of numerous publications and scientific
presentations about ME/CFS. Dr. Cheney was practicing in Lake Tahoe
in 1984-1987, along with Dr. Daniel Peterson, when he helped lead a
research effort with the NIH, the CDC and Harvard University School
of Medicine studying the ME/CFS epidemic in Incline village.
Dr. Nancy Klimas MD
Dr. Klimas is a Professor of Medicine, Psychology, Microbiology and
Immunology at the University of Miami School of Medicine.
As principal investigator of one of the NIH sponsored CFS Research
Centers she leads a multidisciplinary research team representing the
fields of immunology, autonomic medicine, neuroendocrinology,
behavioral psychology, rheumatology, nutrition, and exercise
physiology. The University of Miami CFS Research Center is exploring
interactions between the immune, autonomic and neuroendocrine
systems, and evaluating therapies based on interventions at this
Professor Nora Chapman PhD
Nora Chapman is a Research Scientist at the University of Nebraska
Enterovirus Research Laboratory and Associate Professor at the
University of Nebraska Medical Centre, USA. Dr. Chapman studies
persistent coxsackie infections in murine models of chronic
myocarditis and dilated cardiomyopathy. She and her associates have
demonstrated that selection of defective enterovirus in heart and
other tissues leads to persistent infections despite active
antiviral immune responses.Dr. Chapman is presently studying the
mode of selection of these viruses and the effects of replication of
these viruses upon infected cell function. Dr. Chapman and her
associates at the University of Nebraska are further investigating
Dr. John Chia's work in regards to enterovirus in the gut biopsies.
Dr. John Chia MD
Professor Leonard Jason PhD
Dr Chia is an infectious disease specialist, Torrance, California,
USA. He has published research (Chronic fatigue
syndrome associated with chronic enterovirus infection of the
stomach) on the role of enteroviruses in the aetiology of
ME/CFS - an area which has been implicated as one of the causes by a
number of studies. There are more than 70 different types of
enteroviruses that can affect the central nervous system, heart and
muscles, all of which is consistent with the symptoms of ME/CFS. By
analyzing samples of stomach tissue from 165 patients with CFS, Dr.
Chia's team discovered that 82% of these individuals had high levels
of enteroviruses in their digestive systems. Dr Chia's research may
result in the development of antiviral drugs to treat the
debilitating symptoms of ME/CFS.
Professor Jason has been among the most prolific of all ME/CFS
researchers. For more than a decade, Professor Jason and his team at
DePaul University�s Centre for Community Research in Chicago have
worked to define the scope and impact of ME/CFS worldwide.
Also present at the conference will be representatives of the European
from the Royal colleges has been applied for and we hope to obtain
the maximum credits for the conference, as in previous years.
Discounted rate - Sponsor a Medic:
IiME are again offering a discounted rate for healthcare staff who
are recommended to attend by a local ME Support Group. IiME welcome
all professionals who are working with, or have an interest in,
The Invest in ME conferences have attracted presenters and delegates
from fifteen countries and our DVDs of the conferences have been
distributed to over 20 countries including Europe, USA, Canada,
Australia and New Zealand.
Myalgic Encephalomyelitis is a serious neurological illness
(classified by the World Health Organisation under ICD-10-93.3) that
causes severe problems for an estimated 250,000 people in the UK, of
whom 25,000 are estimated to be children and young people. It is
five times more prevalent than HIV/AIDS in the UK and the leading
cause of long term absence of children from school.
The conference will be a unique opportunity to be informed of the
latest research and information from some of the leading experts on
ME/CFS in the areas of diagnosis, management, treatment,
epidemiology and research.
We welcome everyone who may be interested to attend this major
international conference on ME/CFS.
Registration may be made by using the internet web-site at
Full details of the conference can be found at - http://tinyurl.com/ykdoqkc
Should you have any further questions relating to the conference
please contact us at
We look forward to welcoming you to the conference,
Invest in ME
UK Registered Charity Nr. 1114035
Invest in ME, PO BOX 561, Eastleigh SO50 0GQ, Hampshire, UK
Support ME Awareness - Invest in ME